Cargando…

Novel Immunization Strategies Against Multi-drug-resistant Gram-negative Bacteria

BACKGROUND: Healthcare-related infections due to multi-drug resistant (MDR) Gram-negative bacteria (GNB) such as Acinetobacter baumannii (AB) and carbapenemase producing Klebsiella pneumoniae (KPC) are associated with high mortality rates. New methods to prevent or treat these infections are needed....

Descripción completa

Detalles Bibliográficos
Autores principales:	Youssef, Eman A, Lin, Lin, Zhang, Lina, Ibrahim, Ashraf S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630844/ http://dx.doi.org/10.1093/ofid/ofx163.1223

Ejemplares similares

1705. Filamentous Hemagglutinin Polyclonal Antibodies Protect against Multidrug resistant Gram-negative bacteria
por: Youssef, Eman, et al.
Publicado: (2022)

Equisetin Restores Colistin Sensitivity against Multi-Drug Resistant Gram-Negative Bacteria
por: Zhang, Qi, et al.
Publicado: (2021)

In Vitro Activity of Cefiderocol against Multi-Drug Resistant Carbapenemase-Producing Gram-Negative Pathogens
por: Boyd, Sandra, et al.
Publicado: (2017)

Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria
por: Gokarn, Karuna, et al.
Publicado: (2018)

2433. Evaluation of Meropenem (MEM) in Combination With Colistin (COL) Against Colistin-Resistant Extensively Drug-Resistant (XRD) Gram-Negative Bacteria
por: Singh, Nivedita, et al.
Publicado: (2018)

Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria
por: Youssef, Eman G., et al.
Publicado: (2020)

Transformable nano-antibiotics for mechanotherapy and immune activation against drug-resistant Gram-negative bacteria
por: Li, Rong Sheng, et al.
Publicado: (2023)

2475. Incidence of Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Gram-Negative Bacteria in Brazilian Intensive Care Units
por: Souza, Gregory Lauar, et al.
Publicado: (2019)

Screening for multi-drug-resistant Gram-negative bacteria: what is effective and justifiable?
por: Nijsingh, Niels, et al.
Publicado: (2020)

Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria?
por: Salmi, Chanaz, et al.
Publicado: (2008)

1613. Global 2018 Surveillance of Eravacycline Against Gram-negative Pathogens, Including Multi-drug Resistant Isolates
por: Lijfrock, Virgil, et al.
Publicado: (2020)

244. Predictors and Outcomes of Multi-Drug Resistant Gram-Negative Bacteremia in Patients with Solid Tumours
por: Varghese, George M, et al.
Publicado: (2023)

352 Clinical and molecular characteristics of NDM-1 harboring Multi-Drug Resistant Gram Negative Bacteria at Carilion Medical Center
por: Bansal, Ekta, et al.
Publicado: (2014)

Novel antibiotics effective against gram-positive and -negative multi-resistant bacteria with limited resistance
por: Nicolas, Irène, et al.
Publicado: (2019)

2118. Comparative Analysis of Cefiderocol Mono- and Combination Therapy for Multi-Drug Resistant Gram-negative Infections
por: Ghali, Amer El, et al.
Publicado: (2023)

Veterinary clinic surfaces as reservoirs of multi-drug- and biocide-resistant Gram-negative bacteria
por: Akwuobu, Chinedu A., et al.
Publicado: (2021)

Targeting LPS biosynthesis and transport in gram-negative bacteria in the era of multi-drug resistance
por: Romano, K.P., et al.
Publicado: (2023)

1242. Efficacy and Safety of Intravenous Fosfomycin for the Treatment of Multi-resistant Gram Negative Infections
por: Abdallah, Tasneem, et al.
Publicado: (2021)

1355. Resistance in Gram-Negative Bacteria in the Pediatric Patient Population by Age and Sex
por: Malamet, Benjamin J, et al.
Publicado: (2020)

Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
por: Bergen, Phillip J., et al.
Publicado: (2015)

Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria
por: Eichenberger, Emily M., et al.
Publicado: (2019)

Multi-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B
por: Krzyzanski, Wojciech, et al.
Publicado: (2017)

In vitro Activity of Fosfomycin, Alone and Combined with Cefepime and Meropenem, Against Carbapenemase-Producing Gram-Negative Bacteria
por: Wiederhold, Nathan P, et al.
Publicado: (2017)

High Potency of Melaleuca alternifolia Essential Oil against Multi-Drug Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus aureus
por: Oliva, Alessandra, et al.
Publicado: (2018)

717. Antimicrobial Resistance of Gram-Negative Bacteria in Respiratory Isolates from an Intensive Care Unit in Guatemala
por: Erdmenger, Diego, et al.
Publicado: (2023)

832. Assessment of Risk Factors Associated with Wide-resistance Gram-negative Bacteria Infections
por: Reis, Henry Pablo Lopes Campos e, et al.
Publicado: (2020)

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria
por: Thai, Van C., et al.
Publicado: (2023)

1595. Comparative In Vitro Activity of Imipenem–Relebactam Against Drug-Resistant Gram-Negative Isolates from Pediatric Patients
por: Banerjee, Dithi, et al.
Publicado: (2019)

1725. National Surveillance of Gram-negative Bacteria in Qatar, the Study for Monitoring of Antimicrobial Resistance Trends (SMART): from 2017 to 2019
por: Sid Ahmed, Mazen A, et al.
Publicado: (2022)

Synergistic Effect of Lithocholic Acid with Gentamicin against Gram-Positive Bacteria but Not against Gram-Negative Bacteria
por: Lv, Hongfa, et al.
Publicado: (2022)

In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections
por: Gopichand, Pallam, et al.
Publicado: (2019)

Evaluating the Prevalence and the Risk Factors of Gram-Negative Multi-Drug Resistant Bacteria in Eastern Saudi Arabia
por: Al Hamdan, Aisha S, et al.
Publicado: (2022)

Activity of Specialized Biomolecules against Gram-Positive and Gram-Negative Bacteria
por: Tavares, Tânia D., et al.
Publicado: (2020)

1787. County Level Association Between the Rate of Fluoroquinolone-Resistance Gram Negative Bacteria and Fluoroquinolone Utilization in Kansas
por: Fulmer, Robert D, et al.
Publicado: (2022)

Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria
por: Mousavi, Seyed Mohammad, et al.
Publicado: (2021)

Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling
por: Paranos, Paschalis, et al.
Publicado: (2022)

490 High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
por: Sam, Sharon, et al.
Publicado: (2014)

2122. In Vitro Activity of Cefepime-Taniborbactam Against Clinically Significant Gram-Negative Bacteria Isolated from Patients with Cancer
por: Gerges, Bahgat Z, et al.
Publicado: (2023)

Challenges in antibiotic resistance: Gram negative bacteria
Publicado: (2020)

In vitro Susceptibility Testing of Essential Oils against Gram-positive and Gram-negative Clinical Isolates, including Carbapenem-resistant Enterobacteriaceae (CRE)
por: Patterson, Jan E, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ub8ts77nhqngridnllc73tb10l